Medicare Enrolled

Dr. Patrick Keehan, D.O.

Dermatology · Fort Worth, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
4625 SAINT AMAND CIR, Fort Worth, TX 76126
8177693603
In practice since 2010 (16 years)
NPI: 1366773889 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Keehan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Keehan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Keehan

Dr. Patrick Keehan is a dermatology in Fort Worth, TX, with 16 years in practice. Based on federal Medicare data, Dr. Keehan performed 18,562 Medicare services across 2,241 unique beneficiaries.

Between the years covered by Open Payments, Dr. Keehan received a total of $665,109 from 53 pharmaceutical and/or device companies across 2025 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Keehan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 2% volume in TX$ $665,109 industry payments

Medicare Practice Summary

Medicare Utilization ↗
18,562
Medicare services
Top 2% in TX for dermatology
2,241
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,160 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Photodynamic therapy gel for precancerous skin14,000$1$4
Destruction of precancerous skin growths, 2-14814$5$17
Office visit, established patient (30-39 min)763$86$318
Destruction of precancerous skin growth, 1477$39$169
High dose rate electronic brachytherapy, external469$186$502
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area468$211$680
Office visit, established patient (20-29 min)372$61$226
Skin biopsy, tangential345$71$257
Application of light with debridement to destroy precancer skin growth130$211$711
New patient office visit (30-44 min)127$65$279
Biopsy of related skin growth, each additional growth126$40$127
New patient office visit (45-59 min)86$99$414
Destruction of skin growths (warts/lesions), 1-1478$82$287
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)64$307$978
Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved40$358$1,114
Drug injection, under skin or into muscle31$11$35
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm30$93$616
Office visit, established patient (10-19 min)27$38$141
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm25$225$748
Biopsy of ear24$54$243
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm23$121$450
New patient office or other outpatient visit, 15-29 minutes16$46$174
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm15$144$475
Punch biopsy, first skin growth12$93$318
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$665,109
Total received (2018-2024)
Avg $95,016/year across 7 years
Top 1% in TX for dermatology
53
Companies
2,025
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$627,806 (94.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$21,470 (3.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,833 (2.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$151,148
2023
$95,359
2022
$72,691
2021
$54,072
2020
$32,321
2019
$145,606
2018
$113,913

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$183,204
ABBVIE INC.
$63,889
Novartis Pharmaceuticals Corporation
$58,036
AbbVie, Inc.
$53,630
Janssen Biotech, Inc.
$45,311
Regeneron Healthcare Solutions, Inc.
$38,382
Galderma Laboratories, L.P.
$37,644
AbbVie Inc.
$35,053
Genentech USA, Inc.
$31,556
GENZYME CORPORATION
$30,424
Arcutis Biotherapeutics, Inc.
$26,423
Janssen Scientific Affairs, LLC
$23,675
PFIZER INC.
$7,602
SUN PHARMACEUTICAL INDUSTRIES INC.
$7,594
DUSA Pharmaceuticals, Inc.
$7,212
E.R. Squibb & Sons, L.L.C.
$2,088
LEO Pharma Inc.
$1,859
Lilly USA, LLC
$1,561
Sun Pharmaceutical Industries Inc.
$1,270
Incyte Corporation
$1,180
Dermavant Sciences, Inc.
$1,169
Ortho Dermatologics, a division of Bausch Health US, LLC
$890
Medimetriks Pharmaceuticals, Inc.
$855
Amgen Inc.
$709
Mayne Pharma Inc.
$555
Almirall LLC
$524
MAYNE PHARMA INC.
$352
Biofrontera Inc.
$349
Encore Dermatology Inc.
$278
Journey Medical Corporation
$197
Celgene Corporation
$182
MAYNE PHARMA COMMERCIAL LLC
$181
Paratek Pharmaceuticals, Inc.
$175
VYNE Pharmaceuticals Inc.
$172
Sandoz Inc.
$117
STRATA Skin Sciences, Inc.
$111
Verrica Pharmaceuticals Inc.
$98
SANOFI-AVENTIS U.S. LLC
$95
Kyowa Kirin, Inc.
$92
DERMIRA, INC.
$76
Tactile Systems Technology Inc
$54
Aclaris Therapeutics, Inc.
$42
Promius Pharma LLC
$39
Exeltis, USA Inc.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Otsuka America Pharmaceutical, Inc.
$22
TARO PHARMACEUTICALS USA, INC.
$20
Chiesi USA, Inc.
$19
Taro Pharmaceuticals USA, Inc.
$18
EPI Health, LLC
$18
Medtronic Vascular, Inc.
$14
Mylan Pharmaceuticals Inc.
$14
BAXTER HEALTHCARE
$14
Top 3 companies account for 45.9% of total payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Ameluz · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BRYHALI · Beser · Bimzelx · CIBINQO · COSENTYX · Cabtreo · Cimzia · Clindacin ETZ · Clodan · Clodan Kit · ClosureFast · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Ecoza · Enbrel · Erivedge · Exelderm · FILSUVEZ · FLEXITOUCH · Flexitouch Plus · HALOG · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · HYRIMOZ · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · JUBLIA EFINACONAZOLE · JYNARQUE · KERYDIN · KLISYRI · Ketodan · Klisyri · LEVULAN KERASTICK · LIBTAYO · NUZYRA · Neo-Synalar · Neo-Synalar Cream · Neo-Synalar Cream Kit · ODOMZO · OLUMIANT · OPZELURA · ORACEA · OXISTAT · Odomzo · Olux-E · Otezla · Poteligeo · Promiseb Complete · QBREXZA · REMICADE · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sitavig · Skyrizi · Sotyktu · Sumadan Kit · TALTZ · TARGRETIN · TISSEEL · TREMFYA · TRILUMA · TWYNEO · TargaDox · Tremfya · Trianex · USP) 0.1% · VEREGEN · VTAMA · Winlevi · XOLAIR · XTRAC · Xolair · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for dermatology in TX.

Equivalent to $3,583 per 100 Medicare services performed
Looking for a dermatology in Fort Worth?
Compare dermatologys in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse dermatologys nearby

Geographic Context

Dermatologys within 10 mi
57
Per 100K population
2.7
County median income
$81,905
Nearest hospital
TEXAS HEALTH HARRIS METHODIST HOSPITAL SOUTHWEST F
5.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Keehan is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (speaking/promotional, top 1%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Keehan experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Keehan performed 14,000 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Keehan receive payments from pharmaceutical companies?
Yes. Dr. Keehan received a total of $665,109 from 53 companies across 2,025 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Keehan's costs compare to other dermatologys in Fort Worth?
Dr. Keehan's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Keehan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →